As of April 16, 2025, Fusion Pharmaceuticals (FUSN) has a market cap of $1.83 billion USD. According to our data, Fusion Pharmaceuticals is ranked No.4113 in global market value.
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Novo Nordisk
NVO
|
$286.98 B |
70.023 B
|
![]() Denmark
|
![]() Novo Nordisk A/S
NOVO-B.CO
|
$285.97 B |
64.050 B
|
![]() Denmark
|
![]() Roche
ROG.SW
|
$249.63 B |
38.060 B
|
![]() Switzerland
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Thermo Fisher Scientific
TMO
|
$166.47 B |
0.002 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
![]() USA
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() CVS Health
CVS
|
$87.00 B |
-0.003 M
|
![]() USA
|
![]() Chugai Pharmaceutical
4519.T
|
$77.18 B |
0.794 B
|
![]() Japan
|
![]() CSL
CSL.AX
|
$74.79 B |
-0.212 B
|
![]() Australia
|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
Market Cap | = | FUSN Stock Price | * | FUSN Shares Outstanding |
= | $21.55 | * | 85.06 M | |
= | $1.83 B |